Sulfisoxazole |
“kernicterus” |
Highly albumin bound antibiotic, competitive with endogenous compounds, including bilirubin. This results in higher free bilirubin concentrations and subsequent kernicterus. |
Similar effects can be anticipated for other high protein bound medicines such as ceftriaxone or diphantoine. |
Chloramphenicol |
“grey baby syndrome” |
Impaired glucuronidation capacity, results in chloramphenicol accumulation and subsequent mitochondrial dysfunction, circulatory collapse and death. |
Similar effects can be anticipated for other glucuronidation dependent drug metabolism compounds, such as paracetamol or propofol. |
Kaletra (lopinavir/ritonavir) |
“alcohols” |
Kaletra syrup contains both ethanol and propylene glycol. Impaired metabolic clearance results in accumulation, and subsequent hyperosmolality, lactic acidosis, renal toxicity, central nervous system impairment, cardiac arrhythmia, hemolysis and collapse. |
Explained by ethanol/propylene glycol, competition for hepatic metabolic elimination. |
Codeine by breastfeeding |
“SIDS” |
Exposure to morphine after conversion from codeine, related to an ultrafast metabolizer maternal genotype. The newborn has a poor glucuronidation and renal elimination capacity, resulting in accumulation, sedation, and sudden infant death syndrome. |
Similar effects can be anticipated by other analgesics, such as oxycodone. |
Ceftriaxone + Calcium |
“collaps” |
Simultaneous administration of calcium containing infusions and ceftriaxone results in intravascular precipitate, as observed during autopsy. |
May be similar for other “mixtures” with calcium containing formulations. |
Topical iodide |
“hypothyroidism” |
More pronounced skin permeability and higher body surface area results in more effective absorption of iodine with subsequent suppression of thyroid function. |
Similar for other topical compounds, e.g., steroids and hexachlorophene. |